36 results
P
144 consecutive patients
I/C
first-line DA and SOFIA 6 F Plus catheter for LVOS, rescue stent-retriever
O
successful recanalization (mTICI 2b-3) rate of 75.7%, global rate for functional independence (90-day mRS 0-2) was 40.3%, mTICI 2b-3 rate was 71.6%, overall mTICI2b-3 rate after DA and rescue therapy was 88.9%, pooled estimate of 45.6% for functional independence, mortality within 90 days of 19%, rate of 5.8% of symptomatic intracranial hemorrhage
P
lung disease, li, ipf
I/C
baicalin, no intervention
O
reduced inflammation, decreased apoptosis, protected against progression
P
patients with liver lesions
I/C
LI-RADS algorithm, original studies reporting probability of LR-M for HCC and non-HCC malignancy on MRI
O
pooled percentages of HCC and non-HCC malignancy for LR-M, sources of heterogeneity between reported results
P
Patients with plasmablastic lymphoma (PBL)
I/C
Aggressive chemotherapy, CHOP and DA-EPOCH
O
Complete response, relapse-free survival, overall survival
P
BIPOLAR DISORDER, HEALTHY CONTROLS, UNIPOLAR PARTICIPANTS
I/C
PSYCHOLOGICAL THERAPIES, DEPRESSED PARTICIPANTS, EUTHYMIC PARTICIPANTS
O
DYSFUNCTIONAL ATTITUDES
P
Li QL, Yao MF, Cao RY, Zhao K, Wang XD
I/C
short dental implants, splinted and nonsplinted prostheses
O
survival rates
P
Lemos CA, Verri FR, de Oliveira Neto OB, Cruz RS, Gomes JML, da Silva Casado BG
I/C
high insertion torque, no intervention
O
dental implant success
P
pacientes que passed a spontaneous breathing trial
I/C
cough peak flow assessment, extubation outcome
O
diagnostic performance of the cough peak flow
P
765 participants
I/C
infiltrating nasal packing with local anesthetics, placebo packing
O
pain reduction, anxiety reduction
P
patients with intermediate CAD
I/C
coronary physiology-guided revascularization, angiography-guided revascularization
O
all-cause death, myocardial infarction, target vessel revascularization, major adverse cardiovascular events